Orthofix Medical Inc. (OFIX)
USD 14.56
(-6.34%)
USD 14.56
(-6.34%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 925.31 Million USD | 101.76% |
| 2022 | 458.62 Million USD | -3.78% |
| 2021 | 476.62 Million USD | -9.36% |
| 2020 | 525.86 Million USD | 6.1% |
| 2019 | 495.62 Million USD | 6.21% |
| 2018 | 466.64 Million USD | 15.12% |
| 2017 | 405.35 Million USD | 8.94% |
| 2016 | 372.1 Million USD | -7.03% |
| 2015 | 400.22 Million USD | 1.79% |
| 2014 | 393.18 Million USD | -7.94% |
| 2013 | 427.1 Million USD | -15.3% |
| 2012 | 504.28 Million USD | -27.5% |
| 2011 | 695.55 Million USD | 15.16% |
| 2010 | 603.98 Million USD | 2.29% |
| 2009 | 590.47 Million USD | 5.21% |
| 2008 | 561.21 Million USD | -36.63% |
| 2007 | 885.66 Million USD | 2.71% |
| 2006 | 862.28 Million USD | 81.97% |
| 2005 | 473.86 Million USD | 9.92% |
| 2004 | 431.1 Million USD | 4.34% |
| 2003 | 413.17 Million USD | 87.15% |
| 2002 | 220.77 Million USD | 16.86% |
| 2001 | 188.91 Million USD | -0.8% |
| 2000 | 190.43 Million USD | 39.29% |
| 1999 | 136.72 Million USD | 11.7% |
| 1998 | 122.4 Million USD | 8.41% |
| 1997 | 112.9 Million USD | -0.18% |
| 1996 | 113.1 Million USD | 8.75% |
| 1995 | 104 Million USD | 83.42% |
| 1994 | 56.7 Million USD | 17.88% |
| 1993 | 48.1 Million USD | 31.78% |
| 1992 | 36.5 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 881.99 Million USD | -2.65% |
| 2024 Q1 | 906.05 Million USD | -2.08% |
| 2023 Q3 | 905.65 Million USD | 0.48% |
| 2023 Q1 | 917.13 Million USD | 99.97% |
| 2023 FY | 925.31 Million USD | 101.76% |
| 2023 Q2 | 901.28 Million USD | -1.73% |
| 2023 Q4 | 925.31 Million USD | 2.17% |
| 2022 Q4 | 458.62 Million USD | 1.99% |
| 2022 Q1 | 461.99 Million USD | -3.07% |
| 2022 FY | 458.62 Million USD | -3.78% |
| 2022 Q2 | 461.65 Million USD | -0.07% |
| 2022 Q3 | 449.66 Million USD | -2.6% |
| 2021 Q1 | 513.87 Million USD | -2.28% |
| 2021 Q4 | 476.62 Million USD | -4.75% |
| 2021 Q3 | 500.39 Million USD | -0.32% |
| 2021 FY | 476.62 Million USD | -9.36% |
| 2021 Q2 | 502.01 Million USD | -2.31% |
| 2020 Q3 | 517.13 Million USD | -13.19% |
| 2020 Q1 | 493.49 Million USD | -0.43% |
| 2020 Q2 | 595.7 Million USD | 20.71% |
| 2020 Q4 | 525.86 Million USD | 1.69% |
| 2020 FY | 525.86 Million USD | 6.1% |
| 2019 Q3 | 475.6 Million USD | -2.7% |
| 2019 Q1 | 479.31 Million USD | 2.72% |
| 2019 FY | 495.62 Million USD | 6.21% |
| 2019 Q4 | 495.62 Million USD | 4.21% |
| 2019 Q2 | 488.8 Million USD | 1.98% |
| 2018 Q1 | 409 Million USD | 0.9% |
| 2018 Q4 | 466.64 Million USD | 3.66% |
| 2018 Q2 | 441.76 Million USD | 8.01% |
| 2018 Q3 | 450.16 Million USD | 1.9% |
| 2018 FY | 466.64 Million USD | 15.12% |
| 2017 Q3 | 386.3 Million USD | 5.07% |
| 2017 FY | 405.35 Million USD | 8.94% |
| 2017 Q1 | 354.74 Million USD | -4.66% |
| 2017 Q2 | 367.67 Million USD | 3.65% |
| 2017 Q4 | 405.35 Million USD | 4.93% |
| 2016 Q2 | 364.73 Million USD | 0.54% |
| 2016 Q3 | 376.05 Million USD | 3.1% |
| 2016 FY | 372.1 Million USD | -7.03% |
| 2016 Q4 | 372.1 Million USD | -1.05% |
| 2016 Q1 | 362.77 Million USD | -9.36% |
| 2015 Q4 | 400.22 Million USD | -0.55% |
| 2015 Q1 | 386.71 Million USD | -1.65% |
| 2015 FY | 400.22 Million USD | 1.79% |
| 2015 Q3 | 402.44 Million USD | 3.42% |
| 2015 Q2 | 389.15 Million USD | 0.63% |
| 2014 Q2 | 433.99 Million USD | 3.69% |
| 2014 Q3 | 411.04 Million USD | -5.29% |
| 2014 Q1 | 418.54 Million USD | -2.0% |
| 2014 FY | 393.18 Million USD | -7.94% |
| 2014 Q4 | 393.18 Million USD | -4.35% |
| 2013 FY | 427.1 Million USD | -15.3% |
| 2013 Q3 | 430.05 Million USD | -6.4% |
| 2013 Q2 | 459.45 Million USD | -8.73% |
| 2013 Q1 | 503.38 Million USD | -0.18% |
| 2013 Q4 | 427.1 Million USD | -0.69% |
| 2012 Q1 | 707.58 Million USD | 1.73% |
| 2012 Q3 | 565.07 Million USD | 2.12% |
| 2012 Q4 | 504.28 Million USD | -10.76% |
| 2012 FY | 504.28 Million USD | -27.5% |
| 2012 Q2 | 553.32 Million USD | -21.8% |
| 2011 Q4 | 695.55 Million USD | 6.02% |
| 2011 FY | 695.55 Million USD | 15.16% |
| 2011 Q3 | 656.07 Million USD | 1.4% |
| 2011 Q2 | 647.02 Million USD | 2.49% |
| 2011 Q1 | 631.28 Million USD | 4.52% |
| 2010 Q4 | 603.98 Million USD | 1.08% |
| 2010 Q2 | 589.95 Million USD | 0.02% |
| 2010 FY | 603.98 Million USD | 2.29% |
| 2010 Q1 | 589.82 Million USD | -0.11% |
| 2010 Q3 | 597.53 Million USD | 1.28% |
| 2009 Q2 | 571.78 Million USD | 4.12% |
| 2009 Q3 | 588.77 Million USD | 2.97% |
| 2009 Q4 | 590.47 Million USD | 0.29% |
| 2009 FY | 590.47 Million USD | 5.21% |
| 2009 Q1 | 549.17 Million USD | -2.15% |
| 2008 Q1 | 899.35 Million USD | 1.55% |
| 2008 Q2 | 899.59 Million USD | 0.03% |
| 2008 Q4 | 561.21 Million USD | -3.04% |
| 2008 Q3 | 578.78 Million USD | -35.66% |
| 2008 FY | 561.21 Million USD | -36.63% |
| 2007 FY | 885.66 Million USD | 2.71% |
| 2007 Q1 | 873.49 Million USD | 1.3% |
| 2007 Q2 | 892.49 Million USD | 2.18% |
| 2007 Q3 | 919.45 Million USD | 3.02% |
| 2007 Q4 | 885.66 Million USD | -3.67% |
| 2006 Q3 | 881.9 Million USD | 86.7% |
| 2006 FY | 862.28 Million USD | 81.97% |
| 2006 Q2 | 472.36 Million USD | 4.87% |
| 2006 Q1 | 450.43 Million USD | -4.94% |
| 2006 Q4 | 862.28 Million USD | -2.22% |
| 2005 Q1 | 429.13 Million USD | -0.46% |
| 2005 Q4 | 473.86 Million USD | -5.0% |
| 2005 Q2 | 424.38 Million USD | -1.11% |
| 2005 Q3 | 498.77 Million USD | 17.53% |
| 2005 FY | 473.86 Million USD | 9.92% |
| 2004 Q3 | 429.56 Million USD | 0.1% |
| 2004 Q4 | 431.1 Million USD | 0.36% |
| 2004 Q2 | 429.11 Million USD | 2.42% |
| 2004 Q1 | 418.99 Million USD | 1.41% |
| 2004 FY | 431.1 Million USD | 4.34% |
| 2003 Q2 | 231.19 Million USD | 4.03% |
| 2003 Q1 | 222.23 Million USD | 0.66% |
| 2003 Q4 | 413.17 Million USD | 75.65% |
| 2003 FY | 413.17 Million USD | 87.15% |
| 2003 Q3 | 235.23 Million USD | 1.75% |
| 2002 Q2 | 202.88 Million USD | 6.36% |
| 2002 Q4 | 220.77 Million USD | 5.57% |
| 2002 FY | 220.77 Million USD | 16.86% |
| 2002 Q3 | 209.11 Million USD | 3.07% |
| 2002 Q1 | 190.74 Million USD | 0.97% |
| 2001 Q2 | 188.89 Million USD | 2.09% |
| 2001 FY | 188.91 Million USD | -0.8% |
| 2001 Q4 | 188.91 Million USD | 0.0% |
| 2001 Q1 | 185.02 Million USD | -2.84% |
| 2000 FY | 190.43 Million USD | 39.29% |
| 2000 Q1 | 181.63 Million USD | 32.85% |
| 2000 Q2 | 182.97 Million USD | 0.73% |
| 2000 Q3 | 182.72 Million USD | -0.13% |
| 2000 Q4 | 190.43 Million USD | 4.22% |
| 1999 Q4 | 136.72 Million USD | 0.53% |
| 1999 Q2 | 129 Million USD | 1.02% |
| 1999 Q3 | 136 Million USD | 5.43% |
| 1999 FY | 136.72 Million USD | 11.7% |
| 1999 Q1 | 127.7 Million USD | 4.33% |
| 1998 Q4 | 122.4 Million USD | 0.0% |
| 1998 FY | 122.4 Million USD | 8.41% |
| 1997 FY | 112.9 Million USD | -0.18% |
| 1997 Q4 | 112.9 Million USD | 0.0% |
| 1996 Q4 | 113.1 Million USD | 0.0% |
| 1996 FY | 113.1 Million USD | 8.75% |
| 1995 Q4 | 104 Million USD | 0.0% |
| 1995 Q1 | 62.4 Million USD | 10.05% |
| 1995 FY | 104 Million USD | 83.42% |
| 1994 Q4 | 56.7 Million USD | 0.0% |
| 1994 Q2 | 55 Million USD | 0.0% |
| 1994 FY | 56.7 Million USD | 17.88% |
| 1993 FY | 48.1 Million USD | 31.78% |
| 1993 Q4 | 48.1 Million USD | 0.0% |
| 1992 Q4 | 36.5 Million USD | 0.0% |
| 1992 FY | 36.5 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -2850.057% |
| BrainsWay Ltd. | 62.97 Million USD | -1369.407% |
| Cerus Corporation | 197.74 Million USD | -367.926% |
| Envoy Medical, Inc. | 7.64 Million USD | -12011.453% |
| electroCore, Inc. | 16.38 Million USD | -5546.641% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -11929.576% |
| IceCure Medical Ltd | 16.41 Million USD | -5538.726% |
| Inogen, Inc. | 326.19 Million USD | -183.67% |
| OrthoPediatrics Corp. | 449.58 Million USD | -105.815% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -3293.161% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -5481.244% |
| MaxCyte, Inc. | 268.27 Million USD | -244.914% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -11327.431% |
| Nexalin Technology, Inc. | 3.63 Million USD | -25377.324% |
| PAVmed Inc | 33.11 Million USD | -2693.91% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -545.035% |
| RxSight, Inc. | 182.55 Million USD | -406.883% |
| Sight Sciences, Inc. | 166.65 Million USD | -455.241% |
| SI-BONE, Inc. | 230.42 Million USD | -301.569% |
| TELA Bio, Inc. | 78.04 Million USD | -1085.572% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | -267.324% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -8523.625% |
| Acutus Medical, Inc. | 53.96 Million USD | -1614.817% |
| Talis Biomedical Corporation | 98.34 Million USD | -840.935% |
| Spectral AI, Inc. | 10.69 Million USD | -8554.274% |
| Nano-X Imaging Ltd. | 218.64 Million USD | -323.198% |
| CVRx, Inc. | 115.22 Million USD | -703.023% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -1477.394% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -29602.724% |
| Bioventus Inc. | 810.91 Million USD | -14.108% |
| Venus Concept Inc. | 93.65 Million USD | -888.014% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -3496.948% |
| LivaNova PLC | 2.42 Billion USD | 61.914% |
| 908 Devices Inc. | 202.98 Million USD | -355.863% |
| Alphatec Holdings, Inc. | 805.2 Million USD | -14.916% |
| Nemaura Medical Inc. | 14.56 Million USD | -6253.775% |
| NeuroPace, Inc. | 107.65 Million USD | -759.551% |
| LENSAR, Inc. | 69.58 Million USD | -1229.762% |
| Apyx Medical Corporation | 79.24 Million USD | -1067.737% |
| Cutera, Inc. | 346.29 Million USD | -167.207% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -2102.292% |
| BioSig Technologies, Inc. | 1.79 Million USD | -51363.571% |
| Anika Therapeutics, Inc. | 270.63 Million USD | -241.909% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -2068.995% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 75.534% |
| Axonics, Inc. | 719.92 Million USD | -28.53% |
| Outset Medical, Inc. | 313.8 Million USD | -194.873% |
| IRIDEX Corporation | 34.43 Million USD | -2587.057% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | -128.633% |
| IRadimed Corporation | 92.15 Million USD | -904.074% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -17511.629% |
| INVO Bioscience, Inc. | 20.88 Million USD | -4329.933% |
| Telesis Bio, Inc. | 70.41 Million USD | -1214.163% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -500.454% |
| Varex Imaging Corporation | 1.24 Billion USD | 25.951% |
| Quipt Home Medical Corp. | 247.4 Million USD | -274.004% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -9838.937% |
| Pulmonx Corporation | 178.95 Million USD | -417.077% |
| Dynatronics Corporation | 25.94 Million USD | -3467.059% |
| Modular Medical, Inc. | 13.8 Million USD | -6601.782% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -8526.037% |
| Semler Scientific, Inc. | 78.06 Million USD | -1085.314% |
| InMode Ltd. | 863.28 Million USD | -7.185% |
| Bruker Corporation | 4.24 Billion USD | 78.227% |
| Cytosorbents Corporation | 53.26 Million USD | -1637.334% |
| DexCom, Inc. | 6.26 Billion USD | 85.229% |
| Align Technology, Inc. | 6.08 Billion USD | 84.791% |
| Viveve Medical, Inc. | 25.91 Million USD | -3470.852% |
| ZimVie Inc. | 1.2 Billion USD | 23.232% |
| Movano Inc. | 9.42 Million USD | -9721.834% |
| Cytek Biosciences, Inc. | 497.66 Million USD | -85.93% |
| Nexalin Technology, Inc. | 3.63 Million USD | -25377.324% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -1477.394% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 2.87% |
| Profound Medical Corp. | 43.68 Million USD | -2018.088% |
| Insulet Corporation | 2.58 Billion USD | 64.249% |
| enVVeno Medical Corporation | 48.63 Million USD | -1802.57% |
| Surmodics, Inc. | 185.73 Million USD | -398.196% |
| iCAD, Inc. | 41.41 Million USD | -2134.089% |
| Nuwellis, Inc. | 9.77 Million USD | -9370.983% |
| Biotricity, Inc. | 5.94 Million USD | -15470.813% |
| iRhythm Technologies, Inc. | 433.14 Million USD | -113.628% |
| Aethlon Medical, Inc. | 8.24 Million USD | -11121.405% |
| InspireMD, Inc. | 47.64 Million USD | -1842.185% |
| PAVmed Inc. | 33.11 Million USD | -2693.91% |
| BIOLASE, Inc. | 35.1 Million USD | -2536.15% |
| Beyond Air, Inc. | 56.96 Million USD | -1524.471% |
| FONAR Corporation | 214.24 Million USD | -331.894% |
| AxoGen, Inc. | 196.82 Million USD | -370.116% |
| Vivani Medical, Inc. | 45.79 Million USD | -1920.471% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | -228.781% |
| Inari Medical, Inc. | 674.23 Million USD | -37.239% |
| UFP Technologies, Inc. | 404.13 Million USD | -128.961% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -3854.581% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -9636.967% |
| Tenon Medical, Inc. | 6.34 Million USD | -14483.373% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -9736.452% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -792.75% |
| AdaptHealth Corp. | 4.61 Billion USD | 79.971% |
| Sintx Technologies, Inc. | 15.36 Million USD | -5922.226% |
| NanoVibronix, Inc. | 6.67 Million USD | -13764.474% |
| Quanterix Corporation | 425.01 Million USD | -117.716% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -9838.937% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -1622.253% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 47.004% |
| TransMedics Group, Inc. | 706.04 Million USD | -31.056% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -1364.291% |
| NeuroMetrix, Inc. | 21.42 Million USD | -4218.969% |
| Hyperfine, Inc. | 94.19 Million USD | -882.298% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | -244.443% |
| Biomerica, Inc. | 9.25 Million USD | -9899.081% |
| Bone Biologics Corporation | 3.73 Million USD | -24655.85% |
| AVITA Medical, Inc. | 144.33 Million USD | -541.066% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -18906.041% |
| Silk Road Medical, Inc | 265.3 Million USD | -248.769% |